[1]
2024. Deciphering the therapeutic potential of bergenin in breast cancer: In silico insights into HSP90AA1 and HRAS interaction mediated inhibition of PI3K-Akt and MAPK signaling pathway. Indian Journal of Biochemistry and Biophysics (IJBB). 61, 11 (Oct. 2024), 639–658. DOI:https://doi.org/10.56042/ijbb.v61i11.6391.